Trastuzumab (Herceptin) enhances class I-restricted antigen presentation recognized by HER-2/neu-specific T cytotoxic lymphocytes
収録刊行物
-
- Clin Cancer Res.
-
Clin Cancer Res. 10 2538-2544, 2004